ATE200864T1 - Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid - Google Patents

Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid

Info

Publication number
ATE200864T1
ATE200864T1 AT97937651T AT97937651T ATE200864T1 AT E200864 T1 ATE200864 T1 AT E200864T1 AT 97937651 T AT97937651 T AT 97937651T AT 97937651 T AT97937651 T AT 97937651T AT E200864 T1 ATE200864 T1 AT E200864T1
Authority
AT
Austria
Prior art keywords
controlled release
release tablet
alfuzosine
hydrochloride
alfuzosine hydrochloride
Prior art date
Application number
AT97937651T
Other languages
English (en)
Inventor
Lauretta Maggi
Ubaldo Conte
Pascal Grenier
Guy Vergnault
Alain Dufour
Francois Xavier Jarreau
Clemence Rauch-Desanti
Original Assignee
Sanofi Synthelabo
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE200864(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9610551A external-priority patent/FR2752737B1/fr
Application filed by Sanofi Synthelabo, Jagotec Ag filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE200864T1 publication Critical patent/ATE200864T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97937651T 1996-08-29 1997-08-22 Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid ATE200864T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9610551A FR2752737B1 (fr) 1996-08-29 1996-08-29 Comprime a liberation controlee de chlorhydrate d'alfuzosine
FR9704386 1997-04-10
PCT/FR1997/001515 WO1998008515A1 (fr) 1996-08-29 1997-08-22 Comprime a liberation controlee de chlorhydrate d'alfuzosine

Publications (1)

Publication Number Publication Date
ATE200864T1 true ATE200864T1 (de) 2001-05-15

Family

ID=26232935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97937651T ATE200864T1 (de) 1996-08-29 1997-08-22 Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid

Country Status (36)

Country Link
US (1) US6149940A (de)
EP (1) EP0938318B1 (de)
JP (1) JP3797388B2 (de)
KR (1) KR100364328B1 (de)
CN (2) CN1155382C (de)
AP (1) AP1107A (de)
AR (1) AR009312A1 (de)
AT (1) ATE200864T1 (de)
AU (1) AU724490B2 (de)
BG (1) BG63768B1 (de)
BR (1) BR9713237B1 (de)
CA (1) CA2264250C (de)
CO (1) CO4920217A1 (de)
CY (1) CY2284B1 (de)
CZ (1) CZ295066B6 (de)
DE (1) DE69704712T2 (de)
DK (1) DK0938318T3 (de)
EE (1) EE03855B1 (de)
ES (1) ES2159400T3 (de)
GR (1) GR3036291T3 (de)
HU (1) HU228007B1 (de)
IL (1) IL128146A (de)
IS (1) IS2091B (de)
MX (1) MXPA99001958A (de)
NO (1) NO326206B1 (de)
NZ (1) NZ334018A (de)
OA (1) OA10983A (de)
PL (1) PL191546B1 (de)
PT (1) PT938318E (de)
RU (1) RU2183459C2 (de)
SI (1) SI0938318T1 (de)
SK (1) SK284388B6 (de)
TR (1) TR199900289T2 (de)
TW (1) TW522023B (de)
UA (1) UA69374C2 (de)
WO (1) WO1998008515A1 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720471B1 (en) 1998-04-28 2004-04-13 The Procter & Gamble Company Absorbent articles having reduced rewet with distribution materials positioned underneath storage material
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
FR2784583B1 (fr) * 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
ES2270982T3 (es) 2000-02-04 2007-04-16 Depomed, Inc. Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7163696B2 (en) * 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
US7008979B2 (en) 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US6852238B2 (en) * 2002-08-29 2005-02-08 Steller Technology Company Layered tablet water treatment compositions and method of use
US7309444B2 (en) * 2002-08-29 2007-12-18 Stellar Technology Company Layered tablet water treatment compositions and method of use
SI1551372T1 (en) 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
EP1556014A1 (de) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Alfuzosin enthaltende zusammensetzungen mit verzlängerter freisetzung
MX2007001138A (es) * 2004-07-29 2007-04-19 Sanofi Aventis Comprimido farmaceutico multicapa para la liberacion controlada de ingredientes activos con solubilidad muy dependiente del ph.
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine
US20060062846A1 (en) * 2004-09-17 2006-03-23 Cimex Pharma Ag Alfuzosin tablets and synthesis
US20060062845A1 (en) * 2004-09-17 2006-03-23 Cimex Pharma Ag Alfuzosin tablets and synthesis
ITMI20050391A1 (it) * 2005-03-11 2006-09-12 Ph & T S P A Formulazioni a rilascio controllato di alfuzosin
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
EP2392258B1 (de) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-Informatiksystem
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
US20090238776A1 (en) * 2005-11-09 2009-09-24 Arif Ali Baig Oral Care Compositions and Methods
US20070129460A1 (en) * 2005-11-09 2007-06-07 Jayanth Rajaiah Denture adhesive articles
US20070185237A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles
US7834066B2 (en) * 2005-11-09 2010-11-16 The Procter & Gamble Company Denture adhesive articles
US20070185232A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles
US20070185233A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles
US20070185236A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive compositions
US20070185235A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive compositions
WO2007080509A2 (en) 2006-01-12 2007-07-19 Wockhardt Ltd Sustained release compositions of alfuzosin
KR20140018439A (ko) 2006-05-02 2014-02-12 프로테우스 디지털 헬스, 인코포레이티드 환자 주문형 치료법
EP2719378B1 (de) 2006-06-19 2016-08-31 Alpharma Pharmaceuticals LLC Pharmazeutische Zusammensetzungen
US20080003286A1 (en) * 2006-06-29 2008-01-03 Sathya Narayana Vemula Sustained delivery alfuzosin compositions
WO2008041553A1 (en) 2006-09-26 2008-04-10 Astellas Pharma Inc. Tacrolimus sustained-release preparation
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
JP5916277B2 (ja) 2006-10-25 2016-05-11 プロテウス デジタル ヘルス， インコーポレイテッド 摂取可能な制御活性化識別子
WO2008063626A2 (en) 2006-11-20 2008-05-29 Proteus Biomedical, Inc. Active signal processing personal health signal receivers
US20080138412A1 (en) * 2006-12-06 2008-06-12 Fu-Yung Lin Sustained release alfuzosin hydrochl formulation and method for their production
US20080160081A1 (en) * 2006-12-11 2008-07-03 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making, and methods of use
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
EP2119442A4 (de) * 2006-12-28 2010-12-15 Astellas Pharma Inc Pharmazeutische zusammensetzung von tacrolimus mit verzögerter freisetzung
DK3785599T3 (da) 2007-02-01 2022-11-07 Otsuka Pharma Co Ltd Spiselige eventmarkersystemer
CA3000257C (en) 2007-02-14 2020-04-28 Proteus Digital Health, Inc. In-body power source having high surface area electrode
WO2008102235A1 (en) * 2007-02-20 2008-08-28 Aurobindo Pharma Limited Controlled release formulations of alfuzosin
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
EP2063771A1 (de) 2007-03-09 2009-06-03 Proteus Biomedical, Inc. Körperintegrierte vorrichtung mit ausfahrbarer antenne
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
FI2192946T3 (fi) 2007-09-25 2022-11-30 Elimistön sisäinen laite, jossa on virtuaalinen dipolisignaalinvahvistus
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
ES2840773T3 (es) 2008-03-05 2021-07-07 Otsuka Pharma Co Ltd Sistemas y marcadores de eventos ingeribles de comunicación multimodo
WO2009149029A2 (en) * 2008-06-04 2009-12-10 The Procter & Gamble Company Denture adhesive compositions and methods
US20110009715A1 (en) 2008-07-08 2011-01-13 David O' Reilly Ingestible event marker data framework
JP5715564B2 (ja) 2008-08-13 2015-05-07 プロテウス デジタル ヘルス， インコーポレイテッド 摂取可能デバイスおよびそれを生成する方法
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
JP2012514799A (ja) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
WO2010083360A2 (en) * 2009-01-16 2010-07-22 Mutual Pharmaceutical Company, Inc. Controlled-release formulations
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
SG10201810784SA (en) 2009-04-28 2018-12-28 Proteus Digital Health Inc Highly Reliable Ingestible Event Markers And Methods For Using The Same
EP2432458A4 (de) 2009-05-12 2014-02-12 Proteus Digital Health Inc Einnehmbarer ereignismarker mit verzehrbarem bestandteil
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
CN107411973A (zh) 2010-03-10 2017-12-01 宝洁公司 义齿粘合剂组合物
JP5849947B2 (ja) 2010-03-29 2016-02-03 アステラス製薬株式会社 放出制御医薬組成物
SG10201502720VA (en) 2010-04-07 2015-05-28 Proteus Digital Health Inc Miniature ingestible device
WO2011124953A2 (en) * 2010-04-07 2011-10-13 Lupin Limited Controlled release pharmaceutical compositions of tapentadol
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
EP2642983A4 (de) 2010-11-22 2014-03-12 Proteus Digital Health Inc Einnehmbare vorrichtung mit einem pharmazeutischen produkt
CN102475690B (zh) * 2010-11-30 2016-06-01 安国药品株式会社 内含盐酸阿夫唑嗪的缓释片剂
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
BR112014001397A2 (pt) 2011-07-21 2017-02-21 Proteus Biomedical Inc dispositivo, sistema e método de comunicação móvel
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
CN104487347B (zh) 2012-07-23 2017-09-01 普罗秋斯数字健康公司 用于制造包括电子器件的片剂的方法和系统
DK2910013T3 (en) 2012-10-18 2018-08-06 Proteus Digital Health Inc Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
JP5941240B2 (ja) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド 金属検出器装置、システム、および方法
WO2014197402A1 (en) 2013-06-04 2014-12-11 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
WO2017078557A1 (ru) * 2015-11-05 2017-05-11 Анатолий Викторович ЗАЗУЛЯ Изготовление таблетки с механизмом повышения терапевтической эффективности лекарственного средства нанодозой аналога
BR112019000861B1 (pt) 2016-07-22 2020-10-27 Proteus Digital Health, Inc dispositivo eletrônico
CA3041041A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.

Also Published As

Publication number Publication date
SI0938318T1 (en) 2001-12-31
BG63768B1 (bg) 2002-12-29
CO4920217A1 (es) 2000-05-29
ES2159400T3 (es) 2001-10-01
IS4964A (is) 1999-01-29
NZ334018A (en) 1999-06-29
AU4020197A (en) 1998-03-19
IL128146A (en) 2001-01-11
CN1155382C (zh) 2004-06-30
DE69704712D1 (de) 2001-06-07
EP0938318A1 (de) 1999-09-01
CN100335057C (zh) 2007-09-05
KR100364328B1 (ko) 2002-12-26
JP2000514462A (ja) 2000-10-31
WO1998008515A1 (fr) 1998-03-05
GR3036291T3 (en) 2001-10-31
CA2264250C (en) 2005-07-05
UA69374C2 (uk) 2004-09-15
EE03855B1 (et) 2002-10-15
EE9900090A (et) 1999-10-15
CN1228700A (zh) 1999-09-15
CY2284B1 (en) 2003-07-04
PL191546B1 (pl) 2006-06-30
CZ295066B6 (cs) 2005-05-18
NO990944L (no) 1999-04-27
DE69704712T2 (de) 2001-11-29
AP1107A (en) 2002-09-20
AP9901470A0 (en) 1999-03-31
NO990944D0 (no) 1999-02-26
RU2183459C2 (ru) 2002-06-20
EP0938318B1 (de) 2001-05-02
SK27099A3 (en) 1999-12-10
BG103138A (en) 1999-09-30
PL331862A1 (en) 1999-08-16
BR9713237B1 (pt) 2009-01-13
IL128146A0 (en) 1999-11-30
US6149940A (en) 2000-11-21
CZ65599A3 (cs) 1999-06-16
HU228007B1 (en) 2012-08-28
IS2091B (is) 2006-03-15
HUP9903428A3 (en) 2000-04-28
OA10983A (fr) 2003-03-04
SK284388B6 (sk) 2005-02-04
MXPA99001958A (es) 2005-09-08
PT938318E (pt) 2001-10-30
TW522023B (en) 2003-03-01
HK1020875A1 (en) 2000-05-26
DK0938318T3 (da) 2001-08-20
HUP9903428A2 (hu) 2000-02-28
BR9713237A (pt) 2000-04-04
AU724490B2 (en) 2000-09-21
KR20000035929A (ko) 2000-06-26
CN1543954A (zh) 2004-11-10
CA2264250A1 (en) 1998-03-05
NO326206B1 (no) 2008-10-20
AR009312A1 (es) 2000-04-12
TR199900289T2 (xx) 2000-12-21
JP3797388B2 (ja) 2006-07-19

Similar Documents

Publication Publication Date Title
ATE200864T1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
DE69732113D1 (de) Schnelllösliche tablette enthaltend galanthaminhydrobromid
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
DK1468679T3 (da) Tramadolholdig formulering med styret frigivelse
NO980240D0 (no) Paroxetin-kontrollert frigjörings-blandinger
NO942477L (no) Opioide formuleringer med forlenget, regulert frigivelse
ATE239481T1 (de) Filmueberzogene tabletten von oxacarbazepin
ATE367150T1 (de) Arzneimittel
DE69128569D1 (de) Tablette mit verzögerter Wirkstoffabgabe
DE59707194D1 (de) Direkttablettierhilfsmittel
FI961630A7 (fi) Terapeuttisia aineita
ATE240720T1 (de) Paracetamol enthaltende schlickbare tablette
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
BR9708528A (pt) Terapia com libertação uniforme de droga
FI951300A7 (fi) Alfutsosiinihydrokloridin hitaan vapautumisen galeenisia muotoja
ATE300297T1 (de) Umhüllte tablette enthaltend trimebutin maleat
NO20001375L (no) Legemiddelformulering med kontrollert virkestoffrigivning
NO983090D0 (no) Terapeutiske forbindelser
NO992244D0 (no) AIDS-legemiddel
KR970008018U (ko) 장제용 위패
ZA977766B (en) Tablet with controlled release of alfuzosin hydrochloride.
DE69617790D1 (de) Synchronisierter Zeitschalter
BR9502210A (pt) Travesseiro terapêutico
UA1246S (uk) Таблетка фармацевтична

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification